EMPIRICAL Project
Empirical treatment against cytomegalovirus and tuberculosis in severe pneumonia in HIV-infected infants: a randomized controlled clinical trial
EMPIRICAL is an EDCTP-funded research project that will evaluate whether empirical treatment against cytomegalovirus and tuberculosis improves survival of HIV-infected infants with severe pneumonia.
Where we work
The project in numbers
Queen Elizabeth Central Hospital: Joyce Macheso
Joyce Macheso is lead nurse and the EMPIRICAL point person for screening, recruitment, informed consent, and study procedures at the Queen Elizabeth Central Hospital.
A Hundred of Patients Have Enrolled in EMPIRICAL
We also want to thank the dedication, effort and willingness of all the people who contribute or have contributed since the project kicked off in 2019.
Urgent Versus Post-Stabilization Antiretroviral Treatment (ART) in Hospitalized Children: A Randomized Controlled Trial
Urgent antiretroviral therapy (ART) among hospitalized HIV-infected children may accelerate recovery or worsen outcomes due to immune reconstitution.
Data and Safety Monitoring Board Meeting to Review Safety Data
An external Data and Safety Monitoring Board (DSMB) review recommends that the EMPIRICAL study can continue without modification.
Dr Alfeu Passanduca (UEM/HCM) to Join the 2021-2022 UCGHI GloCal Health Fellowship Programme
He has been selected for this fellowship based on a review conducted by members of the GloCal Leadership Group and Steering Committee.
University of Zimbabwe Clinical Research Centre: Dr Vivian Mumbiro
Dr Vivian Mumbiro is the team leader for screening, recruitment, and follow-up medical management of EMPIRICAL participants during and after hospital admission, at the University of Zimbabwe Clinical Research Centre.
